PT-141 + Oxytocin + N-Acetyl L-Tyrosine + Kisspeptin + VIP (Capsule)

Sexual Wellness Complex — PT-141 / Oxytocin / NALT / Kisspeptin / VIP

A comprehensive sexual wellness blend combining five complementary compounds for enhanced desire, arousal, and bonding.
100% 50% · t½ Time → Serum level
Molecular Weight Not specified
Half-Life Varies
Typical Dose One capsule per prescriber guidance
Cycle Length As needed

Description

This advanced sexual wellness capsule combines five compounds with complementary mechanisms addressing the central nervous system, hormonal, vascular, and psychological dimensions of sexual function. PT-141 (Bremelanotide) is a melanocortin receptor agonist that was FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women, making it the only centrally-acting approved sexual desire medication. Oxytocin is the endogenous neuropeptide associated with bonding, trust, and arousal, with demonstrated effects on sexual motivation and partner bonding. N-Acetyl L-Tyrosine (NALT) provides a bioavailable precursor to dopamine and norepinephrine, supporting the catecholaminergic signaling that underlies sexual motivation and reward. Kisspeptin is a hypothalamic neuropeptide that stimulates GnRH (gonadotropin-releasing hormone) release, which drives downstream LH and FSH production and ultimately sex hormone synthesis. VIP (Vasoactive Intestinal Peptide) is a neuropeptide with vasodilatory and neuromodulatory properties that supports genital blood flow and arousal responses. Together, these five compounds provide a comprehensive approach to sexual wellness through central desire (PT-141), bonding (Oxytocin), dopaminergic motivation (NALT), hormonal optimization (Kisspeptin), and vascular support (VIP).

Key Characteristics

Molecular Formula

Molecular Weight

Half-Life

Administration Routes

Oral capsule

Typical Dose

One capsule (per prescriber guidance)

Frequency

As needed (1–2 hours before)

Investigated Benefits

* Benefits based on preclinical/animal research unless otherwise noted.

Mechanism of Action

“A comprehensive sexual wellness blend combining five complementary compounds for enhanced desire, arousal, and bonding.”

PT-141 activates melanocortin receptors MC3R and MC4R in the hypothalamus and limbic system, triggering central nervous system pathways that increase sexual desire and motivation independent of vascular mechanisms. Oxytocin acts on oxytocin receptors in the limbic system, nucleus accumbens, and spinal cord to enhance bonding, arousal, and the subjective experience of intimacy. NALT is converted to L-Tyrosine and then to L-DOPA and dopamine through the catecholamine synthesis pathway, supporting dopaminergic reward signaling in the mesolimbic system that drives sexual motivation. Kisspeptin activates KISS1R receptors on GnRH neurons in the hypothalamus, stimulating pulsatile GnRH release that drives LH and FSH secretion from the pituitary, ultimately increasing testosterone and estrogen production. VIP activates VIP receptors (VPAC1/VPAC2) on smooth muscle cells in genital vasculature, promoting vasodilation and increased blood flow that supports arousal responses. The combination addresses sexual function at every level: desire (PT-141), bonding (Oxytocin), neurotransmitter support (NALT), hormonal optimization (Kisspeptin), and vascular function (VIP).

Administration Routes

Oral capsule

Key Characteristics

Typical Dose

One capsule (per prescriber guidance)

Frequency

As needed (1–2 hours before)

Cycle Length

As needed

Administration

Oral capsule

Protocol Notes

Take 1–2 hours before desired activity. Nausea is possible — take with light food if needed. Not for daily use.

Reconstitution Guide

Storage Information

Store at room temperature, away from light and moisture.

Quality & Sourcing Standards

When sourcing PT-141 + Oxytocin + N-Acetyl L-Tyrosine + Kisspeptin + VIP (Capsule) for research purposes, the following quality benchmarks should be verified before use.

Purity:

>98% (verified by HPLC)

Certificate of Analysis (COA):

Must be provided by supplier

Endotoxin Testing:

<0.1 EU/mg (prevents bacterial contamination)

GMP Compliance:

Manufactured in cGMP-certified facility

Third-Party Testing:

Independent lab verification preferred

Storage Information

Store at room temperature, away from light and moisture.

FDA Disclaimer

The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.

Research Highlights

1

PT-141 (Bremelanotide) demonstrated significant improvement in sexual desire in Phase III trials

2

Oxytocin demonstrated improved sexual function in human studies

3

Kisspeptin shown to enhance sexual desire in Phase II trials

Compatible Peptides

Peptides commonly used alongside PT-141 + Oxytocin + N-Acetyl L-Tyrosine + Kisspeptin + VIP (Capsule) for synergistic effects.

PT-141

An FDA-approved melanocortin agonist for hypoactive sexual desire disorder with central nervous system mechanism.

Oxytocin

The “bonding hormone” with roles in social connection, stress reduction, sexual function, and gut motility.

Quick Reference

Category

Blends & Combos

Status

Research Only
 

Dose

One capsule (per prescriber guidance)

Frequency

As needed (1–2 hours before)

Cycle

As needed